Browsing Tag
HUMA
1 post
Humacyte (HUMA) posts positive Phase 3 dialysis access data, then raises $50m at a discount on the strength of it
Humacyte (HUMA) posts positive Phase 3 dialysis access data and raises $50M at a discount. FDA filing planned for H2 2026. Read the full executive analysis.